BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

338 related articles for article (PubMed ID: 23889333)

  • 21. The epidemic of methylisothiazolinone: a European prospective study.
    Schwensen JF; Uter W; Bruze M; Svedman C; Goossens A; Wilkinson M; Giménez Arnau A; Gonçalo M; Andersen KE; Paulsen E; Agner T; Foti C; Aalto-Korte K; McFadden J; White I; Johansen JD;
    Contact Dermatitis; 2017 May; 76(5):272-279. PubMed ID: 28032337
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Risk of sensitization to preservatives estimated on the basis of patch test data and exposure, according to a sample of 3541 leave-on products.
    Schnuch A; Mildau G; Kratz EM; Uter W
    Contact Dermatitis; 2011 Sep; 65(3):167-74. PubMed ID: 21692811
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Occupational contact allergy to methylchloroisothiazolinone/methylisothiazolinone and methylisothiazolinone.
    Vauhkala AR; Pesonen M; Suomela S; Kuuliala O; Suuronen K; Aalto-Korte K
    Contact Dermatitis; 2015 Sep; 73(3):150-6. PubMed ID: 26086775
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Contact allergy to preservatives. Analysis of IVDK data 1996-2009.
    Schnuch A; Lessmann H; Geier J; Uter W
    Br J Dermatol; 2011 Jun; 164(6):1316-25. PubMed ID: 21332463
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Periorbital dermatitis in 4779 patients - patch test results during a 10-year period.
    Landeck L; John SM; Geier J
    Contact Dermatitis; 2014 Apr; 70(4):205-12. PubMed ID: 24325408
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Epidemic of Isothiazolinone Allergy in North America: Prevalence Data From the North American Contact Dermatitis Group, 2013-2014.
    Zirwas MJ; Hamann D; Warshaw EM; Maibach HI; Taylor JS; Sasseville D; DeKoven JG; Fransway AF; Mathias CGT; Zug KA; DeLeo VA; Fowler JF; Marks JG; Pratt MD; Belsito DV
    Dermatitis; 2017; 28(3):204-209. PubMed ID: 28509715
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Failures in risk assessment and risk management for cosmetic preservatives in Europe and the impact on public health.
    Schwensen JF; White IR; Thyssen JP; Menné T; Johansen JD
    Contact Dermatitis; 2015 Sep; 73(3):133-41. PubMed ID: 26184096
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Patch Testing for Methylisothiazolinone and Methylchloroisothiazolinone-Methylisothiazolinone Contact Allergy.
    Yu SH; Sood A; Taylor JS
    JAMA Dermatol; 2016 Jan; 152(1):67-72. PubMed ID: 26536492
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prevalence of methylchloroisothiazolinone and methylisothiazolinone contact allergy in facial dermatitis: a single centre Irish study.
    Murad A; Marren P
    J Eur Acad Dermatol Venereol; 2016 Jan; 30(1):60-2. PubMed ID: 25623395
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Further evidence of the methylisothiazolinone epidemic.
    Madsen JT; Andersen KE
    Contact Dermatitis; 2014 Apr; 70(4):246-7. PubMed ID: 24628350
    [No Abstract]   [Full Text] [Related]  

  • 31. Prevalence of sensitization to methylisothiazolinone in an Italian Skin Allergy Unit.
    Gallo R; Signori A; Gervasio S; Parodi A
    G Ital Dermatol Venereol; 2017 Aug; 152(4):338-341. PubMed ID: 26981911
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Methylchloroisothiazolinone/Methylisothiazolinone and methylisothiazolinone allergy.
    Puangpet P; Chawarung A; McFadden JP
    Dermatitis; 2015; 26(2):99-102. PubMed ID: 25757082
    [TBL] [Abstract][Full Text] [Related]  

  • 33. An epidemic of contact allergy to methylisothiazolinone in Finland.
    Lammintausta K; Aalto-Korte K; Ackerman L; Alanko K; Berry P; Hasan T; Kaminska R; Korhonen L; Laukkanen A; Liippo J; Pesonen M; Rantanen T; Riekki R; Suuronen K
    Contact Dermatitis; 2014 Mar; 70(3):184-5. PubMed ID: 24588372
    [No Abstract]   [Full Text] [Related]  

  • 34. The Role of Cleaning Products in Epidemic Allergic Contact Dermatitis to Methylchloroisothiazolinone/Methylisothiazolinone.
    Marrero-Alemán G; Saavedra Santana P; Liuti F; Hernández N; López-Jiménez E; Borrego L
    Dermatitis; 2018; 29(2):77-80. PubMed ID: 29494393
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Methylisothiazolinone.
    Castanedo-Tardana MP; Zug KA
    Dermatitis; 2013; 24(1):2-6. PubMed ID: 23340392
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Recent increase in allergic reactions to methylchloroisothiazolinone/methylisothiazolinone: is methylisothiazolinone the culprit?
    Geier J; Lessmann H; Schnuch A; Uter W
    Contact Dermatitis; 2012 Dec; 67(6):334-41. PubMed ID: 22994269
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Contact allergy to preservatives in patients with occupational contact dermatitis and exposure analysis of preservatives in registered chemical products for occupational use.
    Schwensen JF; Friis UF; Menné T; Flyvholm MA; Johansen JD
    Int Arch Occup Environ Health; 2017 May; 90(4):319-333. PubMed ID: 28168422
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Contact sensitivity to preservatives in Singapore: frequency of sensitization to 11 common preservatives 2006-2011.
    Cheng S; Leow YH; Goh CL; Goon A
    Dermatitis; 2014; 25(2):77-82. PubMed ID: 24603520
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Methylisothiazolinone contact allergy: a review.
    Lundov MD; Krongaard T; Menné TL; Johansen JD
    Br J Dermatol; 2011 Dec; 165(6):1178-82. PubMed ID: 21777214
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Methylisothiazolinone: second 'epidemic' of isothiazolinone sensitization.
    Gameiro A; Coutinho I; Ramos L; Gonçalo M
    Contact Dermatitis; 2014 Apr; 70(4):242-3. PubMed ID: 24628348
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.